SEC Form 4 · accession 0001209191-16-129868
CHIMERIX INC · CMRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Ernest Mario
Director
Period of report
Jun 24, 2016
Accepted (ET)
Jun 28, 2016 · 3:17 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001117480
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jun 24, 2016 | P | 50,000 | $3.6969 | A | 381,440 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F2 | $3.73 | Jun 24, 2016 | A | 9,000 | A | — | Jun 23, 2026 | Common Stock | 9,000 | 9,000 | D |
| Stock Option (Right to Buy)F2 | $3.73 | Jun 24, 2016 | A | 9,634 | A | — | Jun 23, 2026 | Common Stock | 9,634 | 9,634 | D |
Explanation of responses
- F1The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.6399 to $3.70, inclusive. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information will be provided regarding the number of shares purchased or sold at each separate price.
- F2The shares subject to the option vest in a series of 12 equal monthly installments from the date of grant; provided, however, that the option shall become fully vested on the date that is the earlier of (i) the one-year anniversary of the date of grant and (ii) the date of the Company's 2017 annual stockholder meeting.